Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,089,611 | +21,486 | $262.02M | $316.29M | 69.29% | +$54.27M |
| Verona Pharma plc (VRNA)ADS | 615,352 | 615,352 | 0 | $58.20M | $65.66M | 14.39% | +$7.46M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,316,806 | 1,316,806 | 0 | $12.33M | $20.27M | 4.44% | +$7.94M |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,960,659 | +419,650 | $4.95M | $10.95M | 2.40% | +$6.00M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $6.64M | $10.91M | 2.39% | +$4.27M |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | $5.29M | $8.98M | 1.97% | +$3.70M |
| COMPASS Pathways plcADS(CMPS) | 1,198,418 | 1,198,418 | 0 | $3.36M | $6.87M | 1.50% | +$3.51M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 564,625 | +564,625 | $0 | $6.54M | 1.43% | +$6.54M |
| Biomea Fusion, Inc.(BMEA) | 2,048,757 | 2,048,757 | 0 | $3.69M | $4.14M | 0.91% | +$450.7K |
| Scholar Rock Holding Corporation(SRRK) | 0 | 77,031 | +77,031 | $0 | $2.87M | 0.63% | +$2.87M |
| CalciMedica, Inc.(CALC) | 521,114 | 521,114 | 0 | $833.8K | $1.60M | 0.35% | +$769.1K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $616.9K | $825.5K | 0.18% | +$208.5K |
| Marker Therapeutics, Inc.(MRKR) | 325,370 | 325,370 | 0 | $497.8K | $290.4K | 0.06% | -$207.4K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 88,607 | 88,607 | 0 | $211.8K | $243.7K | 0.05% | +$31.9K |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 0 | -2,834,910 | $1.04M | $0 | — | -$1.04M |